Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

N-(Trimethyl-sil-yl)methane-sulfonamide.

ABSTRACT: There are two mol-ecules in the asymmetric unit of the title compound, C(4)H(13)NO(2)SSi. In the crystal, mol-ecules are linked via inter-molecular N-H?O hydrogen bonds, forming chains along [001]. The crystal studied was an inversion twin, the refined ratio of twin domains being 0.61?(9):0.39?(9).

SUBMITTER: McWilliams AR

PROVIDER: S-EPMC3050205 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

N-(Trimethyl-sil-yl)methane-sulfonamide.

McWilliams Andrew R AR Gezahegna Sossina S Lough Alan J AJ

Acta crystallographica. Section E, Structure reports online 20101211 Pt 1

There are two mol-ecules in the asymmetric unit of the title compound, C(4)H(13)NO(2)SSi. In the crystal, mol-ecules are linked via inter-molecular N-H⋯O hydrogen bonds, forming chains along [001]. The crystal studied was an inversion twin, the refined ratio of twin domains being 0.61 (9):0.39 (9). ...[more]

PMID: 21522802

Similar Datasets

[?-1,3-Bis(trimethyl-sil-yl)cyclo-penta-dien-yl]dichlorido[?-(trimethyl-sil-yl)cyclo-penta-dien-yl]titanium(IV).

Project description:In the title compound, [Ti(C(8)H(13)Si)(C(11)H(21)Si(2))Cl(2)], the Ti(IV) atom is bonded to two Cl atoms, one 1,3-bis-(trimethyl-sil-yl)cyclo-penta-dienyl (Si(2)Cp) and one (trimethyl-sil-yl)cyclo-penta-dienyl ring (SiCp). The Si(2)Cp centroid-titanium distance is 2.0763?(10)?Å and the SiCp centroid-titanium distance is 2.0793?(10)?Å. The angle subtended at the Ti atom by the centroids of both cyclo-penta-dienyl rings is 131.22?(4)° and the Cl-Ti-Cl angle is 94.14?(2)°.

| S-EPMC3238619 | biostudies-literature

4,4'-Bis(trimethyl-sil-yl)-2,2'-bipyridine.

Project description:In the mol-ecule of title compound, C(16)H(24)N(2)Si(2), the pyridine rings are nearly planar (r.m.s. deviation = 0.002 Å).

| S-EPMC3238818 | biostudies-literature

1-Benzyl-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium chloride monohydrate.

Project description:The title compound, C(18)H(23)N(2)Si(+)·Cl(-)·H(2)O, was synthesized from 1-[(trimethyl-sil-yl)meth-yl]benzimidazole and benzyl chloride in dimethyl-formamide. The benzimidazole ring system is approximately planar, with a maximum deviation of 0.022 (2) Å, and makes an angle of 74.80 (12)° with the phenyl ring. The crystal packing is stabilized by O-H⋯Cl, C-H⋯Cl, C-H⋯O and C-H⋯π inter-actions between symmetry-related mol-ecules together with π-π stacking inter-actions between the imidazolium and benzene rings [centroid-centroid distance = 3.5690 (15) Å] and between the benzene rings [centroid-centroid distance = 3.7223 (14) Å].

| S-EPMC3007035 | biostudies-literature

2,3,5,6-Tetra-fluoro-1,4-bis-(trimethyl-sil-yl)benzene.

Project description:The asymmetric unit of the title compound, C(12)H(18)F(4)Si(2), contains two independent mol-ecules, both lying on inversion centers. The C(arene)-Si distances are significantly longer than in the analogous non-fluorinated compound. The packing of the mol-ecules results in a herringbone motif in the ac plane.

| S-EPMC3344037 | biostudies-literature

2-(4-Hy-droxy-phen-yl)-3-(trimethyl-sil-yl)propanaminium chloride.

Project description:In the title crystal structure, C(12)H(22)NOSi(+)·Cl(-), anions and cations are linked via O-H?Cl, N-H?Cl and N-H?O hydrogen bonds to form a two-dimensional network parallel to (101). Within the hydrogen-bonded network, R(4) (2)(22) ring motifs are stacked along [010].

| S-EPMC3201541 | biostudies-literature

2-Phenyl-3-(trimethyl-sil-yl)propan-1-aminium chloride.

Project description:The title compound, C(12)H(22)NSi(+)·Cl(-), contains two formula units in the asymmetric unit and is a hydro-chloride salt in which the amine N atom is protonated and the NH(3) (+) group forms hydrogen bonds with the Cl(-) anion, forming a ribbon in the c-axis direction.

| S-EPMC3201342 | biostudies-literature

3-(Trimethyl-sil-yl)prop-2-ynyl p-toluene-sulfonate.

Project description:In the title compound, C(13)H(18)O(3)SSi, the SO(3) group displays a partial rotational (ca 50°) disorder about the C-S bond, with relative proportions 0.7744 (13):0.2256 (13). This disorder also forces the propynyl CH(2) group to be disordered.

| S-EPMC3247495 | biostudies-literature

1,2-Bis{2-[2-(trimethyl-sil-yl)ethyn-yl]phen-yl}ethane-1,2-dione.

Project description:The title compound, C(24)H(26)O(2)Si(2), has C(2) crystallographic symmetry. The dihedral angle between the aromatic rings is 84.5 (2)°. The acetyl-ene group is slightly non-linear, with angles at the acetyl-ene C atoms of 175.7 (2) and 177.0 (2)°. In the crystal structure, only van de Waals interactions occur.

| S-EPMC3435835 | biostudies-literature

1-Phenyl-5-{[2-(trimethyl-sil-yl)eth-yl]sulfon-yl}-1H-tetra-zole.

Project description:The title compound, C(12)H(18)N(4)O(2)SSi, was synthesized to be employed in a Julia-Kocieński olefination. In the mol-ecule, the dihedral angle between the phenyl ring and the tetra-zole ring is 41.50 (5)°. The significantly longer Si-C(methyl-ene) bond [1.8786 (13) Å] and the shortened adjacent C-C bond [1.5172 (18) Å], as well as the significant deviation of the corresponding Si-C-C angle [114.16 (9)°] from the ideal tetra-hedral angle, can be attributed to the β-effect of silicon. In the crystal, mol-ecules are held together by van der Waals inter-actions.

| S-EPMC3200698 | biostudies-literature

1-(Prop-2-en-1-yl)-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium bromide monohydrate.

Project description:In the title compound, C(14)H(21)N(2)Si(+)·Br(-)·H(2)O, the benzimidazole ring system is almost planar [maximum deviation = 0.021 (2) Å]. In the crystal, O-H⋯Br and C-H⋯O hydrogen bonds link the ions via the O atoms of the water mol-ecules. In addition, there are π-π stacking inter-actions between the centroids of the benzene and imidazole rings of the benzimidazole ring system [centroid-centroid distances = 3.521 (3) and 3.575 (2) Å].

| S-EPMC3008061 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data